Japan Diabetes Care Devices Size, Share, Trends and Growth Report – Global Opportunities & Forecast, 2023-2030
Japan Diabetes Care Devices Overview
Diabetes care devices are generally used to measure the glucose level in the diabetic patient’s body and aid the delivery of insulin into the patient’s body. There are basically two types of diabetes care devices: blood glucose monitoring device and insulin delivery device. The regular monitoring of diabetes helps in improving the outcomes and adjusting treatment in real-time. These devices are widely used in hospitals, clinics, and other clinical centers.
To have an edge over the competition by knowing the market dynamics and current trends of “Japan Diabetes Care Devices Market,” request for Sample Report here
Major Shale Gas Market Drivers
The Japan Diabetes Care Devices market is experiencing an upsurge in demand during the next six years. The increasing awareness regarding the diabetes treatment and management and the rising government emphasis on enhancing the healthcare sector. As per the IDF, 463 million people have diabetes in the world, out of which 163 million people in the Western Pacific region have diabetes. This number is anticipated to rise and touch 212 million by the end of 2045. The prevalence of diabetes in adults is 7.9 %, while the total cases of diabetes in adults amounted to 7,390,500.
According to the health survey conducted by the Ministry of Health, Labor, and Welfare, approximately 20 million people in Japan has either contracted or were at risk of contracting diabetes in 2016. The accelerating number of diabetes patients in Japan is one of the major factors that is responsible for the growth of the market in the coming years. Japan is witnessing an increase in the number of older people, who are more vulnerable to diabetes, and the rise in obesity due to lack of physical activities and unhealthy diet patterns are certain other factors that are further increasing the growth of the market. Furthermore, continuous technological advancements in the field of diabetes devices have opened new doors for the growth of the market. In addition to this, the rising need for faster and safer diagnosis and treatment of diabetes is further boosting the market growth. On the other edge of the spectrum, the adverse effect related to some of the diabetes care devices is one of the major factors that is likely to hamper the growth of the market.
Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report
On the basis of product type, the blood glucose monitoring device segment is projected to grow at a higher CAGR during the forecast period. This is mainly due to the increasing prevalence of diabetes, along with the growing number of geriatric population and rising focus on self-care. Furthermore, continuous technological advancement in blood glucose monitoring devices is further energizing the segment growth over the coming years. The rising number of online marketing strategies by the key vendors is driving the growth of the segment in the market.
Based on end-users, the home care settings segment is projected to dominate the Japan diabetes care devices market during the forecast period. The accelerating adoption of blood sugar monitoring and insulin delivery devices in the home care setting is a major factor that is contributing to the growth of the segment. The diabetes care devices offers numerous benefits such as remote monitoring, high convenience, portability, and considerable precision which is further attracting a large number of consumers to opt for different types of diabetes care devices at their homes. The COVID-19 has encouraged individuals to opt for self-monitoring of diabetes rather than visiting hospitals or clinics in order to eliminate the possibility of contracting the coronavirus.
In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here
Key Developments:
-
- In 2018, Dexcom Inc., entered into an agreement with Terumo Corporation to distribute the continuous glucose monitoring (CGM) devices exclusively in Japan. The products consist safety mechanism that automatically issues an alert when the level of blood glucose is high or low.
Segments covered in the Report:
The Japan Diabetes Care Devices market has been segmented on the basis of product type, end-user. Based on the product type, the market is segmented into blood glucose monitoring device and insulin delivery device. Based on the end-user, the market is segmented into homecare settings, hospitals, and others. The other segment is further segmented into clinics and ambulatory surgical centers.
For detailed scope of the “Japan Diabetes Care Devices Market” report request a Sample Copy of the report
Report Coverage |
Details |
Market Revenues (2022) |
USD Million |
Market Base Year |
2022 |
Market Forecast Period |
2023-2030 |
Base Year & Forecast Units |
Revenues (USD Million) |
Market Segment | By Product Type, By End User |
Regional Coverage | Japan |
Companies Profiled | Profiles of Top 10 Major Companies Operating in “Japan Diabetes Care Devices Market” |
25% Free Customization Available | We will customize this report up to 25% as a free customization to address our client’s specific requirements |
Market Segmentation
Japan Diabetes Care Devices market by Product Type
-
- Blood Glucose Monitoring Device
- Insulin Delivery Device
Japan Diabetes Care Devices market by End-User
-
- Hospitals
- Homecare Setting
- Others
- Published Date: Jun-2023
- Report Format: Excel/PPT
- Report Code: UP1773-001001
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Japan Diabetes Care Devices Size, Share, Trends and Growth Report – Global Opportunities & Forecast, 2023-2030
$ 4,499.00 – $ 6,649.00